6467 — TAHO Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for TAHO Pharmaceuticals, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	81.2	106	230	496	390
Net Total Accounts Receivable
Net Total Receivables	1.39	0.028	0.289	0.872	0.801
Prepaid Expenses
Total Other Current Assets
Total Current Assets	83.4	111	233	499	394
Net Property, Plant And Equipment	12.3	4.33	23.5	24.9	22.5
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	109	139	283	561	456
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13	46.5	59.7	33.1	26
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	45	46.5	76.5	44.5	31.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	64.2	92	207	516	424
Total Liabilities & Shareholders' Equity	109	139	283	561	456
Total Common Shares Outstanding